Drawing for DAVITA HOME DIALYSIS CONNECT

USPTO serial 87438191

DAVITA HOME DIALYSIS CONNECT

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DIBLE, JONATHON I
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DAVITA HOME DIALYSIS CONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

MIRIAM D. TRUDELL Sheridan Ross P.C.1560 Broadway, Suite 1200Denver, CO 80202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software in the nature of a mobile application for use in accessing health and wellness programs, personalized medicine, health care services integrated with local care, remote medical monitoring, on-call remote access to health coaching and intervention services, virtual medical care, health care records review and management, and health data collection; Downloadable software in the nature of a mobile application for analyzing and reporting data received from remote medical monitoring devices; Downloadable software in the nature of a mobile application for remote communication and networking of medical data, voice data, video data, and scheduling data for remote medical monitoring and consultation; Downloadable software in the nature of a mobile application for use with medical patient monitoring equipment for receiving, processing, transmitting and displaying data; Downloadable computer software, namely, software for the transmission, recording, reproduction, display, organization, management, manipulation and review of messages, text, images, files, audio, video and audio-visual content and other data for the facilitation of communications between two or multiple users via computer networks; Virtual reality training simulation software in the field of kidney disease and treatment; Sensors for scientific use to be worn by a human to gather human biometric dataACTIVE—
010Portable medical devices with sensors to monitor the health of a patient wearing or carrying the device; Sensors for medical use to be worn by a human to gather human biometric dataACTIVE—
035Supply chain management servicesACTIVE—
036Insurance counseling services, namely, advising and assisting others in choosing and enrolling in health insurance plans and programsACTIVE—
041Educational services, namely, providing clinician training in the field of kidney disease and treatment; Educational services, namely, providing patient education and training in the field of kidney disease and treatmentACTIVE—
042Software as a service (SAAS) services featuring software for allowing real-time access to medical professionals by medical patients via telephone, video, email, mobile devices or a global computer network, for scheduling of medical and laboratory appointments online, voice, video, chat, or text via mobile device, computer, and any device, allowing medical telemetry services online, voice, video chat, or text via mobile, computer, phone and any device, and allowing medical consultations provided via phone, online chat or videoconferencing; Providing temporary use of online non-downloadable software for patients to connect with physicians and medical service providers and to schedule interviews and receive medication and prescriptions via video chat; Providing a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents; Providing temporary use of non-downloadable software to provide telemedicine services via the internet, namely, real time video consultations, on-line video chats, e-mails and instant messaging between physicians and patients and allow users to consult information about their health and medical records and obtain general information about health; Providing temporary use of non-downloadable software to provide virtual medical clinic services; Providing temporary use of non-downloadable software to manage virtual health care clinics and medical clinics; Providing a website featuring on-line non-downloadable software for use in accessing health programs, personalized medicine, concierge health care services, health care services integrated with local care, remote medical monitoring, on-call remote access to health coaching and intervention services, virtual medical care, health care records review and management, and health data collection; Providing a website featuring on-line non-downloadable software for analyzing and reporting data received from remote medical monitoring devices; Providing a website featuring on-line non-downloadable software for remote communication and networking of medical data, voice data, video data, and scheduling data for remote medical monitoring and consultation; Providing a website featuring on-line non-downloadable software for use with medical patient monitoring equipment for receiving, processing, transmitting and displaying data; Software as a service (SAAS) services featuring software for use in predictive modeling and predictive analytics; Software as a service (SAAS) services, namely, hosting software for use by others for use with decision support tools, namely, medical diagnosis based on the patient symptoms, medications, and medical records and compliance with known treatment guidelines; Software as a service (SAAS) services featuring software for use in electronically signing consents, prescriptions, and other documentsACTIVE—
044Medical and pharmaceutical consulting services provided by phone, email or by video chat; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Interactive medical monitoring and alert service for reminding clients of medicinal dosage and prescription refills for medical treatment purposes; Medical and pharmaceutical consultations provided via phone, online chat or videoconferencing; Health care services; Medical services; Managed health care services; Health care services, namely, disease management programs; Medical assistance services provided via telecommunication and global computer networks for individuals with health problems through the use of wearable medical devices with automated alert and monitoring capacity; Providing an internet website for medical professionals and medical patients featuring information relating to health programs, personalized medicine, concierge health care services, health care services integrated with local care, remote medical monitoring, on-call remote access to health coaching and intervention services, virtual medical care, health care records review and management, and health data collection; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; Providing social work services, namely, providing psychosocial support and counselingACTIVE—
045Providing emotional counseling and emotional support services for dialysis patients; Organizing and conducting support groups in the field of kidney disease and treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 22, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 22, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 25, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 23, 2019EX3GSOU EXTENSION 3 GRANTED—
Oct 23, 2019EXT3SOU EXTENSION 3 FILED—
Oct 23, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 22, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 20, 2019EX2GSOU EXTENSION 2 GRANTED—
May 20, 2019EXT2SOU EXTENSION 2 FILED—
May 20, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 17, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 15, 2018EX1GSOU EXTENSION 1 GRANTED—
Nov 15, 2018EXT1SOU EXTENSION 1 FILED—
Nov 15, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 17, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 22, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 27, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 27, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 7, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2018ALIEASSIGNED TO LIE—
Feb 12, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2017DOCKASSIGNED TO EXAMINER—
May 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 9, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance